A phase 1B trial of masofaniten (EPI-7386) in patients with metastatic castration-resistant prostate cancer (MCRPC) Meeting Abstract
| Authors: | Laccetti, A.; Iannotti, N.; Pachynski, R.; Carthon, B.; Chi, K. N.; Smith, M.; Saad, F.; Pili, R.; Tu, W.; Kwan, E. M.; Wyatt, A. W.; Villaluna, K.; Younginger, B.; Moigne, R. L.; Cesano, A. |
| Abstract Title: | A phase 1B trial of masofaniten (EPI-7386) in patients with metastatic castration-resistant prostate cancer (MCRPC) |
| Meeting Title: | 24th Annual Meeting of the Society of Urologic Oncology (SUO 2024) |
| Journal Title: | Urologic Oncology: Seminars and Original Investigations |
| Volume: | 43 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Dec 4-6 |
| Meeting Location: | Dallas, TX |
| ISSN: | 1078-1439 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2025-03-01 |
| DOI: | 10.1016/j.urolonc.2024.12.005 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 2 -- Source: Cinahl |
